id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-P-0134-0004,FDA,FDA-2005-P-0134,"Petition Denial from FDA CDER to Lachman Consultant Services, Inc.",Other,PDN-Petition Denial,2008-12-24T05:00:00Z,2008,12,2008-12-24T05:00:00Z,,2024-11-12T18:26:40Z,,0,0,09000064807dcaef
FDA-2005-P-0134-0003,FDA,FDA-2005-P-0134,"Citizens Petition from Lachman Consultant Services, Inc.",Other,CP-Citizen Petition,2008-12-24T05:00:00Z,2008,12,2008-12-24T05:00:00Z,,2024-11-12T18:24:31Z,,0,0,090000648043fe1e
FDA-2005-P-0134-0005,FDA,FDA-2005-P-0134,"Attachment 1 - Approved Drug Products with Therapeutic Equivalence Evaluations (Electronic Orange Book), April 25, 2005 re Citizens Petition from Lachman Consultant Services, Inc.",Supporting & Related Material,Background Material,2008-12-24T05:00:00Z,2008,12,,,2024-11-12T18:30:08Z,,0,0,09000064807f8ef6
FDA-2005-P-0134-0001,FDA,FDA-2005-P-0134,"Acknowledgement Letter from FDA DDM to Lachman Consultant Services, Inc.",Other,Acknowledgement Letter/Receipt,2005-04-27T04:00:00Z,2005,4,,,2024-11-12T18:21:08Z,,0,0,090000648043fe1d
FDA-2005-P-0134-0002,FDA,FDA-2005-P-0134,"Acknowledgement Letter from FDA DDM to Lachman Consultant Services, Inc.",Other,Acknowledgement Letter/Receipt,2005-04-27T04:00:00Z,2005,4,,,2024-11-12T18:23:02Z,,0,0,090000648043fe20